title: Computer-assisted structure-activity correlations of halodideoxynucleoside analogs as potential anti-HIV drugs.
abstract: Analysis of the structure-anti-HIV activity correlations of halo dideoxynucleosides (ddN's) in the public domain was accomplished through computer substructure searching, retrieval and sorting of in vitro anti-HIV data. In the survey, selectivity index (ratio of cytotoxicity to the potency in inhibiting HIV replication in vitro) was used to rank compounds in congeneric groups. Factors contributing to the anti-HIV activity, e.g. the nature and location of the halogen on the sugar or the base and its stereochemical configuration, could not be generalized for all the halogenated ddN's. Conclusions were drawn for specific classes within the pyrimidine and purine series, with compounds further divided into halo substitutions at the sugar 2',3',4'-positions or in the pyrimidine or purine ring systems. At the 3'-position, only a fluoro substitution enhanced the activity of the dideoxypyrimidine nucleosides. A 2'-ara fluoro substituent increased the activity of purine ddN's but decreased activity of pyrimidine ddN's. Halogenation of the side chain in acyclic adenine and 2,6-diaminopurine nucleosides improved their anti-HIV activity. Halo substitution at the 6- or 2'-ara position of selected purine ddN's resulted in compounds with increased lipophilicity, chemical stability and retention of anti-HIV activity. The number of halodideoxynucleosides tested as anti-HIV reagents suggested that this class of compounds is well studied.
authors.affiliation: Division of AIDS, National Institute of Allergy and Infectious Diseases, NIH, Rockville, MD 20892.
authors.forename: M
authors.initials: M
authors.lastname: Nasr
authors.forename: J
authors.initials: J
authors.lastname: Cradock
authors.forename: M I
authors.initials: MI
authors.lastname: Johnston
mesh_terms: D000998:Antiviral Agents / Q000737:chemistry / Q000494:pharmacology*; D003198:Computer Simulation; D015224:Dideoxynucleosides / Q000737:chemistry / Q000494:pharmacology*; D006678:HIV / Q000187:drug effects*; D006219:Halogens / Q000737:chemistry / Q000494:pharmacology*; D013329:Structure-Activity Relationship
chemical_list: D000998:Antiviral Agents; D015224:Dideoxynucleosides; D006219:Halogens